Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Abbott' Humira: A Much-Needed Win for This Blockbuster Drug
Motley Fool
Thursday, August 30, 2012 - 9:37am
tags:
Humira, Abbott, ulcerative colitis
Ariad Pharmaceuticals Gearing Up For Ponatinib's Approval
Seeking Alpha
Wednesday, August 29, 2012 - 5:54pm
tags:
Ariad Pharmaceuticals, Ponatinib, Pfizer, Bristol-Myers Squibb, Novartis
FDA approves wider use for J&J Nucynta ER pain drug
Reuters
Wednesday, August 29, 2012 - 5:47pm
tags:
FDA, JNJ, Nucynta, painkillers
What Lilly's Failure Means For Addex
Seeking Alpha
Wednesday, August 29, 2012 - 5:46pm
tags:
Addex, Eli Lilly, schizophrenia, LY2140023, pomaglumetad methionil, ADX71149, JNJ
Big Pharma betting billions in high-stakes hunt for the next Lipitor
Fierce Biotech
Wednesday, August 29, 2012 - 12:21pm
tags:
Big Pharma, Lipitor, Anacetrapib, Merck, Plavix, Pfizer, Bristol-Myers Squibb, PCSK9 inhibitor, Sanofi, Regeneron, darapladib, Roche, GSK
The Next Catalyst For Arena
Seeking Alpha
Wednesday, August 29, 2012 - 12:19pm
tags:
Arena Pharmaceuticals, Belviq
ArQule Shares Drop on Lung Cancer Drug Safety Concern
Minyanville
Wednesday, August 29, 2012 - 12:17pm
tags:
Arqule, lung cancer, tivantinib
Cataract risk for kids on Vertex's cystic fibrosis pill -FDA
Reuters
Wednesday, August 29, 2012 - 12:15pm
tags:
cataracts, FDA, cystic fibrosis, Vertex, Kalydeco
Pfizer Gets Creative Replacing Revenue Losses In 2012
Seeking Alpha
Wednesday, August 29, 2012 - 12:14pm
tags:
Pfizer
3 Things to Watch With ImmunoGen
Motley Fool
Wednesday, August 29, 2012 - 12:13pm
tags:
Immunogen
Will Pharma Companies Get Out of Alzheimer's Disease R&D?
Forbes
Wednesday, August 29, 2012 - 12:13pm
tags:
R&D, Alzheimer's disease, Eli Lilly, Pfizer, JNJ
Novartis Smoker’s Cough Treatment Beats Glaxo’s Advair in Trial
Bloomberg Businessweek
Wednesday, August 29, 2012 - 10:49am
tags:
Novartis, COP, GSK, Advair, smoker's cough, QVA149
Synergy Acquires FV-100 from BMY
Yahoo/Zacks
Wednesday, August 29, 2012 - 10:38am
tags:
Bristol-Myers Squibb, FV-100, Synergy Pharmaceuticals, shingles
J&J's Zytiga to be reviewed faster by FDA for additional use
Reuters
Wednesday, August 29, 2012 - 10:37am
tags:
JNJ, Zytiga, FDA, prostate cancer
4 Low-Debt Pharmaceutical Stocks Backed By Analysts
Seeking Alpha
Wednesday, August 29, 2012 - 10:35am
tags:
Endocyte, Astex, Rigel Pharmaceuticals, Impax Labs
Abbott’s Humira Backed By FDA Advisory Panel For Colitis
Bloomberg
Wednesday, August 29, 2012 - 8:31am
tags:
Abbott, FDA, Humira, ulcerative colitis
Eli Lilly to stop developing schizophrenia drug
Yahoo/Reuters
Wednesday, August 29, 2012 - 8:30am
tags:
Eli Lilly, schizophrenia, pomaglumetad methionil
Stribild: It's FDA-Approved, but Will It Sell?
Motley Fool
Wednesday, August 29, 2012 - 8:29am
tags:
FDA, HIV, Gilead, Stribild
5 Pharmaceutical Companies With EMA Or MHRA Catalysts This Year
Seeking Alpha
Tuesday, August 28, 2012 - 12:27pm
tags:
Sucampo, Savient, Gentium, Alexza, Horizon Pharma
Medicines Co. says cardiology group guidelines recommend Angiomax over Heparin
Yahoo/Fly on the Wall
Tuesday, August 28, 2012 - 12:26pm
tags:
Medicines Company, Angiomax, Heparin, myocardial infarction

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.